The content of this page is aimed at providing information and guidance on Immunotherapy Toxicity to healthcare professionals. Information for patients can be found HERE.
All Wales Immunotherapy Toxicity Group
Chair: Tracy Parry, SACT Lead Pharmacist for Cancer Network and Lead Cancer Services Pharmacist for Betsi Cadwaladr University Health Board
Deputy Chair: Dr Ricky Frazer, Consultant Medical Oncologist, Velindre Cancer Centre
The All Wales Immunotherapy Toxicity Group has been established by the Wales Cancer Network as a subgroup of the All Wales Acute Oncology Service (AOS) Group and All Wales Systemic Anti-Cancer Therapy (SACT) Group. It aims to provide a strategic lead for immunotherapy toxicity priorities and a forum for the ratification of all Wales developments enabling a coordinated approach to service provision.
For further information on the All Wales Immunotherapy Toxicity Group, please contact WCN.WalesCancerNetwork@wales.nhs.uk